Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children

Pediatric Infectious Disease Journal

Volumn 22, Issue 3, 2003, Pages 256-262

  Stutzmann Meier, Patricia ^a   Freiburghaus, Simone ^a   Martin, Andrea ^a   Heiniger, Nadja ^a   Troller, Rolf ^a   Aebi, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Immune response; Infant; Moraxella catarrhalis; Outer membrane protein; Saliva

Indexed keywords

ANTIGEN; HEMAGGLUTININ; IMMUNOGLOBULIN A; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN USPA1; OUTER MEMBRANE PROTEIN USPA2; PROTEIN; PROTEIN COPB; TRANSFERRIN; TRANSFERRIN BINDING PROTEIN B; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MUCOSA; MUTATIONAL ANALYSIS; NASOPHARYNX; NOSE MUCOSA; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SALIVA LEVEL;

AGE DISTRIBUTION; BACTERIAL OUTER MEMBRANE PROTEINS; CHILD, PRESCHOOL; COHORT STUDIES; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOBLOTTING; IMMUNOGLOBULIN G; INCIDENCE; INFANT; MALE; MORAXELLA (BRANHAMELLA) CATARRHALIS; NASOPHARYNX; PROBABILITY; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, BACTERIAL; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0344211401     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200303000-00011     Document Type: Article

References (46)

1. Gehanno P, Panajotopoulos A, Barry B, et al. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J 2001;20:570-3.
2. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001;20:654-62.
3. Faden H, Harabuchi Y, Hong JJ. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis 1994;169:1312-17.
4. Vives M, Garcia ME, Saenz P, et al. Nasopharyngeal colonization in Costa Rican children during the first year of life. Pediatr Infect Dis J 1997;16:852-8.
5. Faden H, Wasielewski R, Wolf J, Krystofik D, Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children: Tonawanda/ Williamsville Pediatrics. J Infect Dis 1997;175:1440-5.
6. Vaneechoutte M, Verschraegen G, Claeys G, van den Abeele AM. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990;28:2674-80.
7. Seghal SC, Shaimy I. Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and pediatric patients: detection and significance. Infection 1994;22:193-6.
8. Goldblatt D, Turner MW, Levinsky RJ. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis 1990;162:1128-35.
9. Chen D, Barniak V, VanDerMeid KR, McMichael JC. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect Immun 1999;67:1310-16.
10. Faden H, Hong JJ, Pahade N. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads. Ann Otol Rhinol Laryngol 1994;103:522-4.
11. Faden H, Hong JJ, Murphy TF. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun 1992;60:3824-9.
12. Samukawa T, Yamanaka N, Hollingshead S, Murphy TF, Faden H. Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media. J Infect Dis 2000;181:1842-5.
13. Samukawa T, Yamanaka N, Hollingshead S, Klingman K, Faden H. Immune response to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract. Infect Immun 2000;68:1569-73.
14. Karjalainen H, Koskela M, Luotonen J, Herva E, Sipila P. Antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusions during early phase of acute otitis media. Acta Otolaryngol 1990;109:111-18.
15. Mathers K, Leinonen M, Goldblatt D. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media. Pediatr Infect Dis J 1999;18:982-8.
16. Vaneechoutte M, Verschraegen G, Claeys G, van den Abeele AM. Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp. J Clin Microbiol 1988;26:2544-8.
17. Stutzmann Meier P, Troller R, Grivea IN, Syrogiannopoulos GA, Aebi C. The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine 2002;20:1754-60.
18. Murphy TF, Loeb MR. Isolation of the outer membrane of Branhamella catarrhalis. Microb Pathog 1989;6:159-74.
19. Aebi C, Maciver I, Cope LD, Latimer JL, McCracken GH Jr, Hansen EJ. A protective epitope of Moraxella catarrhalis is encoded by two genes. Infect Immun 1997;65:4367-77.
20. Pearson MM, Lafontaine ER, Wagner NJ, St. Geme JWI, Hansen EJ. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect Immun 2002;70:4523-33.
21. Forsgren A, Brant M, Mollenkvist A, et al. Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis. J Immunol 2001;167:2112-20.
22. Helminen ME, Maciver I, Latimer JL, et al. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival of this organism in vivo. J Infect Dis 1993;168:1194-201.
23. Luke NR, Russo TA, Luther N, Campagnari AA. Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane protein B1 defined monoclonal antibody 11C6. Infect Immun 1999;67:681-7.
24. Luke NR, Campagnari AA. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infect Immun 1999;67:5815-9.
25. Aebi C, Stone B, Beucher M, et al. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun 1996;64:2024-30.
26. Sethi S, Surface JM, Murphy TF. Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis. Infect Immun 1997;65:3666-71.
27. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966;15:45-52.
28. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972;124:21-37.
29. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J 1994;13:983-9.
30. Aniansson G, Alm B, Andersson B, et al. A prospective cohort study on breast-feeding and otitis media in children. Pediatr Infect Dis J 1994;13:183-8.
31. Leinonen M, Luotonen J, Herva E, Valkonen K, Makela PH. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis 1981;144:570-4.
32. Sanchez S, Troncoso G, Criado MT, Ferreiros C. Interspecific neisserial high molecular weight proteins able to induce natural immunity responses are strongly correlated with in vitro bactericidal activity. Vaccine 2002;20:2964-71.
33. Harabuchi Y, Faden H, Yamanaka N, Duffy L, Wolf J, Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis 1994;170:862-6.
34. Simell B, Kilpi TL, Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis 2002;186:1106-14.
35. Karjalainen H, Koskela M, Luotonen J, Herva E, Sipila P. Occurrences of antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion and serum during the course of acute otitis media. Acta Otolaryngol 1990;111:112-19.
36. Chen D, McMichael JC, VanDerMeid KR, et al. Evaluation of a 74-kDa transferrin binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate. Vaccine 1999;18:109-18.
37. Bhushan R, Kirkham C, Sethi S, Murphy TF. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect Immun 1997;65:2668-75.
38. Helminen ME, Maciver I, Latimer JL, et al. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis 1994;170:867-72.
39. Mathers KE, Goldblatt D, Aebi C, Yu RH, Schryvers AB, Hansen EJ. Characterisation of an outer membrane protein from Moraxella catarrhalis. FEMS Immunol Med Microbiol 1997;19:231-6.
40. McMichael JC. Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections. Microbes Infect 2000;2:561-8.
41. Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH Jr, Hansen EJ. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance the pulmonary clearance of the pathogen in an animal model. Infect Immun 1993;61:2003-10.
42. Wald ER, Rohn DD, Chiponis DM, Blattner MM, Reisinger KS, Wucher FP. Quantitative cultures of middle-ear fluid in acute otitis media. J Pediatr 1983;102:259-61.
43. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001;14:430-45.
44. Zhang Q, Choo S, Finn A. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA and CbpB in adenoidal B cells from children. Infect Immun 2002;70:5363-9.
45. Hou Y, Hu W, Hirano T, Gu X. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model. Vaccine 2002;20:2375-81.
46. Kyd J, John A, Cripps A, Murphy TF. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis. Vaccine 2000;18:398-406.